SGK1 Gene
Overview
Mermaid diagram (expand to render)
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">SGK1 Gene</th>
</tr>
<tr>
<td class="label">Brain Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">[Hippocampus](/brain-regions/hippocampus)</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cerebral [Cortex](/brain-regions/cortex)</td>
<td>High</td>
</tr>
<tr>
<td class="label">Substantia Nigra</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Hypothalamus</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/autoimmune" style="color:#ef9a9a">Autoimmune</a>, <a href="/wiki/cardiac" style="color:#ef9a9a">Cardiac</a>, <a href="/wiki/depression" style="color:#ef9a9a">Depression</a>, <a href="/wiki/fibrosis" style="color:#ef9a9a">Fibrosis</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">48 edges</a></td>
</tr>
</table>
The SGK1 Gene (Serum/Glucocorticoid-Regulated Kinase 1) is a serine/threonine protein kinase that plays critical roles in cellular stress response, neuronal survival, and glucocorticoid-mediated signaling. This page provides comprehensive information about its molecular function, disease associations, and therapeutic implications.
SGK1 Gene
Introduction
Sgk1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. [@nishimoto2015]
SGK1 (Serum/Glucocorticoid-Regulated Kinase 1) is a serine/threonine protein kinase encoded by the SGK1 gene located on chromosome 6q23 (6q23.2). The gene spans approximately 25 kb and consists of 13 exons[@shoemaker2006]. [@tai2009]
The SGK1 gene encodes multiple splice variants: [@brunet2001]
- SGK1 isoform 1: Full-length protein (433 amino acids)
- SGK1 isoform 2: Truncated variant with alternative start site
- SGK1 isoform 3: Tissue-specific expression pattern
The protein contains an N-terminal catalytic domain, a hydrophobic motif, and a C-terminal regulatory domain[@nishimoto2015]. [@webster1993]
Function
SGK1 is a member of the AGC kinase family (PKA/PKB/PKC-related) with diverse cellular functions: [@firestone2003]
Ion Channel Regulation
SGK1 activates the epithelial sodium channel (ENaC), TRPV5, and other ion channels through phosphorylation[@tai2009]. This regulation affects neuronal excitability and calcium homeostasis. [@liu2018]
Cell Survival Pathways
SGK1 promotes cell survival through Akt-independent pathways by phosphorylating pro-apoptotic proteins like BAD and FOXO transcription factors[@brunet2001]. [@jia2020]
Glucocorticoid Response
SGK1 mediates many effects of glucocorticoids and is rapidly upregulated by glucocorticoid receptor activation[@webster1993]. This connection is particularly relevant to stress-related neurodegeneration.
Stress Response
SGK1 is activated by various cellular stresses:
- Osmotic stress
- UV irradiation
- Oxidative stress
- Hypoxia
Neuroprotection
SGK1 promotes neuronal survival through multiple mechanisms:
- Inhibiting glycogen synthase kinase-3β (GSK-3β)
- Activating [mTOR](/entities/mtor) signaling
- Protecting against mitochondrial dysfunction
Expression Pattern
SGK1 is widely expressed throughout the brain and peripheral tissues:
Peripheral expression includes kidney, heart, liver, and adipose tissue[@firestone2003].
Disease Associations
Alzheimer's Disease
SGK1 plays complex roles in AD pathophysiology:
- Upregulation in AD brain: SGK1 expression is increased in AD hippocampus and cortex[@shoemaker2006]
- [Tau](/proteins/tau) phosphorylation: SGK1 may modulate [tau](/proteins/tau) phosphorylation through [GSK-3β](/entities/gsk3-beta) interaction, though this relationship is complex[@liu2018]
- Amyloid-beta response: SGK1 is involved in cellular responses to [Aβ](/proteins/amyloid-beta)-induced neurotoxicity
- Glucocorticoid connection: Dysregulated cortisol signaling in AD may involve SGK1 pathways
Parkinson's Disease
In PD, SGK1 has been studied for its neuroprotective potential:
- Dopaminergic neuron survival: SGK1 may protect dopaminergic [neurons](/entities/neurons) from oxidative stress through Nrf2 activation[@jia2020]
- Genetic associations: Some studies link SGK1 variants to PD risk, though results are inconsistent
- DJ-1/PARK7 interaction: May interact with the DJ-1/PARK7 pathway involved in PD pathogenesis
Stroke and Cerebral Ischemia
SGK1 shows neuroprotective effects in ischemic conditions:
- Hypoxia response: SGK1 is upregulated under hypoxic conditions and promotes survival
- Cerebral ischemia models: SGK1 overexpression reduces infarct size in mouse models
- [Blood-brain barrier](/entities/blood-brain-barrier): May protect BBB integrity during stroke
Amyotrophic Lateral Sclerosis (ALS)
Emerging evidence suggests SGK1 involvement in ALS:
- Motor neuron survival pathways may be modulated by SGK1
- Energy metabolism in motor neurons involves SGK1 signaling
Therapeutic Implications
SGK1 represents a promising therapeutic target:
Neuroprotective Strategies
- SGK1 activators: Small molecule activators under development for neuroprotection
- Gene therapy: Viral vector-mediated SGK1 overexpression approaches
Challenges
- Broad tissue expression creates off-target concerns
- Balancing neuroprotective vs. potential oncogenic effects
- Delivery across the blood-brain barrier
Key Publications
Shoemaker LB, et al. (2006) Serum- and glucocorticoid-regulated kinase 1 in Alzheimer's disease. J Neurochem 99:681-694. PMID: 16800848(https://pubmed.ncbi.nlm.nih.gov/16800848/)
Nishimoto T, et al. (2015) SGK1 is a novel therapeutic target for Parkinson's disease. Mol Brain 8:48. PMID: 26242482(https://pubmed.ncbi.nlm.nih.gov/26242482/)
Tai DJ, et al. (2009) SGK1 is a key mediator of glucocorticoid action in the brain. Mol Endocrinol 23:1299-1312. PMID: 19407220(https://pubmed.ncbi.nlm.nih.gov/19407220/)
Brunet A, et al. (2001) Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol Cell Biol 21:952-965. PMID: 11157737(https://pubmed.ncbi.nlm.nih.gov/11157737/)
Webster MK, et al. (1993) Characterization of sgk, a novel member of the serine/threonine protein kinase gene family which is transcriptionally induced by glucocorticoids and serum. Mol Cell Biol 13:2031-2040. PMID: 8455598(https://pubmed.ncbi.nlm.nih.gov/8455598/)
Firestone GL, et al. (2003) The role of SGK1 in hormone-regulated tumorigenesis. Mol Cell Endocrinol 206:23-31. PMID: 12554073(https://pubmed.ncbi.nlm.nih.gov/12554073/)
Liu L, et al. (2018) SGK1 regulates tau phosphorylation in Alzheimer's disease. J Alzheimers Dis 62:333-343. PMID: 29475943(https://pubmed.ncbi.nlm.nih.gov/29475943/)
Jia Y, et al. (2020) SGK1 protects dopaminergic neurons against oxidative stress via Nrf2 activation. Redox Biol 36:101672. PMID: 32745789(https://pubmed.ncbi.nlm.nih.gov/32745789/)Background
The study of Sgk1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Neurotrophic Factors](/therapeutics/neurotrophic-factor-therapies) GSK3B
- [AKT1](/proteins/akt1)
- [Stroke](/diseases/stroke)
- [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
- Cell Survival Pathways
External Links
- [NCBI Gene: SGK1](https://www.ncbi.nlm.nih.gov/gene/6446)
- [UniProt: SGK1](https://www.uniprot.org/uniprot/O00141)
- [GeneCards: SGK1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=SGK1)
- [OMIM: SGK1](https://www.omim.org/entry/604466)
References
[Shoemaker LB, et al, (2006) Serum- and glucocorticoid-regulated kinase 1 in Alzheimer's disease (2006)](https://pubmed.ncbi.nlm.nih.gov/16800848/)
[Nishimoto T, et al, (2015) SGK1 is a novel therapeutic target for Parkinson's disease (2015)](https://pubmed.ncbi.nlm.nih.gov/26242482/)
[Tai DJ, et al, (2009) SGK1 is a key mediator of glucocorticoid action in the brain (2009)](https://pubmed.ncbi.nlm.nih.gov/19407220/)
[Brunet A, et al, (2001) Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a) (2001)](https://pubmed.ncbi.nlm.nih.gov/11157737/)
[Webster MK, et al, (1993) Characterization of sgk, a novel member of the serine/threonine protein kinase gene family which is transcriptionally induced by glucocorticoids and serum (1993)](https://pubmed.ncbi.nlm.nih.gov/8455598/)
[Firestone GL, et al, (2003) The role of SGK1 in hormone-regulated tumorigenesis (2003)](https://pubmed.ncbi.nlm.nih.gov/12554073/)
[Liu L, et al, (2018) SGK1 regulates tau phosphorylation in Alzheimer's disease (2018)](https://pubmed.ncbi.nlm.nih.gov/29475943/)
[Jia Y, et al, (2020) SGK1 protects dopaminergic neurons against oxidative stress via Nrf2 activation (2020)](https://pubmed.ncbi.nlm.nih.gov/32745789/)Pathway Diagram
The following diagram shows the key molecular relationships involving SGK1 Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)